PROCEPT BioRobotics Corporation Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PROCEPT BioRobotics Corporation stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $4.50M, a 2.70% increase year-over-year.
- PROCEPT BioRobotics Corporation stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $222.00K, a 82.90% decline year-over-year.
- PROCEPT BioRobotics Corporation stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $1.08M, a 37.14% decline year-over-year.
- PROCEPT BioRobotics Corporation stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $4.38M, a 17.35% decline year-over-year.
- PROCEPT BioRobotics Corporation stock issued during period, value, stock options exercised for fiscal 2025 was $11.19M, a 28.26% decline from fiscal 2024.
- PROCEPT BioRobotics Corporation stock issued during period, value, stock options exercised for fiscal 2024 was $15.60M, a 156.19% increase from fiscal 2023.
- PROCEPT BioRobotics Corporation stock issued during period, value, stock options exercised for fiscal 2023 was $6.09M, a 5.10% decline from fiscal 2022.
- PROCEPT BioRobotics Corporation stock issued during period, value, stock options exercised for fiscal 2022 was $6.42M, a 53.37% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $4.50M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $222.00K 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $11.19M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $1.08M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $4.38M 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $1.30M 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $15.60M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $1.72M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $5.30M 10-Q · filed 2025-11-05 | |
| 2024-03-31 | $2.59M 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $6.09M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $414.00K 10-Q · filed 2024-10-28 | |
| 2023-06-30 | $2.43M 10-Q · filed 2024-10-28 | |
| 2023-03-31 | $380.00K 10-Q · filed 2024-10-28 | |
| 2022-12-31 | $6.42M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $777.00K 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $2.86M 10-Q · filed 2023-11-02 | |
| 2022-03-31 | $1.29M 10-Q · filed 2023-11-02 | |
| 2021-12-31 | $4.18M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $855.00K 10-Q · filed 2022-11-04 | |
| 2021-06-30 | $1.42M 10-Q · filed 2022-11-04 | |
| 2021-03-31 | $1.23M 10-Q · filed 2022-11-04 | |
| 2020-12-31 | $2.28M 10-K · filed 2022-03-22 | |
| 2020-09-30 | $51.00K 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $979.00K 10-Q · filed 2021-11-05 | |
| 2020-03-31 | $1.02M 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |